2011
DOI: 10.1161/strokeaha.110.593350
|View full text |Cite
|
Sign up to set email alerts
|

Effect of Normobaric Oxygen Therapy in a Rat Model of Intracerebral Hemorrhage

Abstract: Background and Purpose-Normobaric oxygen (NBO) therapy may be neuroprotective in acute ischemic stroke.However, how NBO may affect intracerebral hemorrhage is unclear. We tested NBO in a rat model of striatal intracerebral hemorrhage. Methods-Intracerebral hemorrhage was induced by stereotactic injection of collagenase Type VII (0.5 U) into the right striatum of male Sprague-Dawley rats. One hour later, rats were randomized into controls (nϭ13) versus NBO treatment (nϭ13). NBO was applied for 2 hours. Hemorrha… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

1
11
0

Year Published

2011
2011
2023
2023

Publication Types

Select...
7
1

Relationship

1
7

Authors

Journals

citations
Cited by 22 publications
(12 citation statements)
references
References 16 publications
1
11
0
Order By: Relevance
“…Furthermore, NBO did not appear to worsen postischemic brain hemorrhage, edema, or blood-brain barrier damage, and it may not increase matrix metalloproteinase levels or various other markers of oxidative stress (Veltkamp, et al, 2006, Liu, et al, 2009). In addition, a recent study demonstrated that NBO did not worsen outcomes in a rat model of intracerebral hemorrhage (ICH), suggesting that treatments could potentially be started even before a definitive diagnosis to distinguish ischemic versus hemorrhagic stroke (Fujiwara, et al, 2011). Based on these preclinical animal studies, NBO treatment was extended to humans in a few early proof-of-concept clinical trials.…”
Section: Introductionmentioning
confidence: 99%
“…Furthermore, NBO did not appear to worsen postischemic brain hemorrhage, edema, or blood-brain barrier damage, and it may not increase matrix metalloproteinase levels or various other markers of oxidative stress (Veltkamp, et al, 2006, Liu, et al, 2009). In addition, a recent study demonstrated that NBO did not worsen outcomes in a rat model of intracerebral hemorrhage (ICH), suggesting that treatments could potentially be started even before a definitive diagnosis to distinguish ischemic versus hemorrhagic stroke (Fujiwara, et al, 2011). Based on these preclinical animal studies, NBO treatment was extended to humans in a few early proof-of-concept clinical trials.…”
Section: Introductionmentioning
confidence: 99%
“…Furthermore, ketamine, an N-methyl d-aspartate (NMDA) receptor antagonist, may possibly reduce NMDA receptor-dependant excitotoxicity, and therefore ameliorate outcomes in brain injury models. Volatile anesthetics, such as isoflurane, are alternatively used in preclinical ICH research and hold unique advantages over injectable agents, including the quick alteration of anesthesia depth and short recovery times 19 . The main disadvantage of gas anesthesia is the need of elaborate equipment (vaporizer, flow-meter, mask breathing circuit) as well as the possibility of human gas exposure.…”
Section: Discussionmentioning
confidence: 99%
“…On the contrary, the described phenomenon of hematoma disappearance could be used to improve accuracy of MRI, especially because we (and others) 16 demonstrated that NBO appears safe after ICH ( Figure 6). For instance, we demonstrated here that perihematoma magnetic resonance PWI becomes feasible after a 30-minute preparation period of NBO.…”
Section: Potential Implications For Clinical Practicementioning
confidence: 92%